BAKER BROS. ADVISORS LP 13D/13G Filings for Akero Therapeutics, Inc. (AKRO)

BAKER BROS. ADVISORS LP 13D and 13G filings for Akero Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-14
4:21 pm
Unchanged		2023-12-3113GAkero Therapeutics, Inc.
AKRO		BAKER BROS. ADVISORS LP2,368,378
4.300%		0
(Unchanged)		Filing
2023-02-14
4:00 pm
Purchase		2022-12-3113GAkero Therapeutics, Inc.
AKRO		BAKER BROS. ADVISORS LP2,368,378
5.100%		2,368,378increase
(New Position)		Filing